anti-HIV1-RT antibody product blog
Tags: Antibody; Monoclonal Antibody; HIV1-RT; anti-HIV1-RT antibody;
The HIV1-RT n/a (Catalog #MBS531805) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s HIV1-RT can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).If antibody concentration is 1 mg/ml, suggested starting dilutions:
ELISA: 1:1,000
WB: 1:500 to 1:1000. Researchers should empirically determine the suitability of the HIV1-RT n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Biological Significance: In the fields of molecular biology and biochemistry, a reverse transcriptase, also known as RNA-dependent DNA polymerase, is a DNA polymerase enzyme that transcribes single-stranded RNA into double-stranded DNA. It also helps in the formation of a double helix DNA once the RNA has been reverse transcribed into a single strand cDNA. Normal transcription involves the synthesis of RNA from DNA; hence, reverse transcription is the reverse of this.
Cross Reactivity: Binds to recombinant RT (HIV-1, IIIB) in ELISA and Western Blot. Not epitope mapped.
Not tested for sterility or endotoxin content. Immunogen: Purified full length recombinant RT (HIV-1, IIIB) produced in E.coli Expression System.
Dry Ice Shipment: Extra charge fee may add to your shipping cost as dry ice is required to ship this product. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HIV1-RT are readily searchable from our website. Different antibodies against the same target such as HIV1-RT may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.